Experience

AGC Pharma Chemicals

• Spain
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Process Development Manager

  • Jul 2022 - Present



Quimica Sintetica S.A.

• Alcalá de Henares y alrededores, España

• R&D Head

  • Jul 2015 - Jun 2022

  Responsible of new product development (NPD) and its transfer to the plant as a robust industrial process. We worked with technical transfers and process optimizations in order to meet market demand. Technically respond to costumer's inquiries and regulatory affairs. Familiar with US/European pharmacopeia and cGMP. Conduct process technology transfers from different plants. Responsible of new product development (NPD) and its transfer to the plant as a robust industrial process. We worked with technical transfers and process optimizations in order to meet market demand. Technically respond to costumer's inquiries and regulatory affairs. Familiar with US/European pharmacopeia and cGMP. Conduct process technology transfers from different plants.



Maprimed S.A.

• Research & Development Manager

  • Mar 2014 - Jun 2015

  I conducted a highly skilled team consisting of analytical and organic chemists. Responsable of getting rapid process development, optimization of existing processes in order to meet market demands, and, assuring reliable methods for in-process controls, analysis of intermediates and APIs. It was defined a risk and process safety assesment, considering environmental issues. I was directly involved in getting technical support to regulatory affairs and customer's requests.

• Research & Development Head

  • Nov 2012 - Feb 2014



Lilly - PCB

• Research Chemist

  • Nov 2008 - Nov 2011

  Working actively in Eli Lilly projects. My efforts are focused on the design of the synthetic route to deliver libraries of compounds for lead optimization. Deliver the requested quantities in a timely manner of key intermediates and final compounds. Reported directly to the research advisor, located in Eli Lilly Madrid. Been active in the project, participating in discussions at meetings and in the design of alternative synthetic routes. Working actively in Eli Lilly projects. My efforts are focused on the design of the synthetic route to deliver libraries of compounds for lead optimization. Deliver the requested quantities in a timely manner of key intermediates and final compounds. Reported directly to the research advisor, located in Eli Lilly Madrid. Been active in the project, participating in discussions at meetings and in the design of alternative synthetic routes.



IRBM (MRL-Italy)

• Senior Research Chemist

  • Jan 2005 - Oct 2008

  Identify pre-clinical candidates for two anti-cancer therapeutic targets, and support work-up of the candidate compound. Design, synthesis and characterization of small molecules at hit-to-lead and lead optimization stages. Had the opportunity to collaborate in different disciplines and learn the features of a molecule to become a drug. Had a full view of the drug discovery process; from the target validation to the pre-clinical assays. Acquaintance in the design and synthesis of target molecules based on in vivo and in vitro data, modelling analysis, DMPK and toxicity data, patents and clinical data of competitors compounds. Authoring and reviewing manuscripts including publications in peer-reviewed journals and patents. Critical presentations of internal and external research, and oral presentations in project meeting settings and conferences. Supervision of graduate students with periodic perfomance evaluation. Show less



Memorial Sloan Kettering Cancer Center

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Postdoctoral Research Fellow

  • Nov 2002 - Nov 2004

  I contributed to the design and synthesis of new inhibitors of the Hsp90 molecular chaperones. As well, we developped of a purine-scaffold novel class of Hsp90 binders Biological studies of their activity on cancer cells, especially focusing on Her2 tyrosine kinase. The work was advised by Dr. Gabriela Chiosis. I contributed to the design and synthesis of new inhibitors of the Hsp90 molecular chaperones. As well, we developped of a purine-scaffold novel class of Hsp90 binders Biological studies of their activity on cancer cells, especially focusing on Her2 tyrosine kinase. The work was advised by Dr. Gabriela Chiosis.



University of Ottawa

• Canada
• Higher Education
• 700 & Above Employee

• Postdoctoral Research Fellow

  • Oct 2001 - Nov 2002

  My research was focused on photochemical studies of carbanions derived from Ketoprofen using Laser Flash Photolysis technique. Besides, I contributed on the design and synthesis of pre-fluorescent probes to detect free radicals in biological and chemical systems. The work was advised by Dr. J.C. Scaiano. My research was focused on photochemical studies of carbanions derived from Ketoprofen using Laser Flash Photolysis technique. Besides, I contributed on the design and synthesis of pre-fluorescent probes to detect free radicals in biological and chemical systems. The work was advised by Dr. J.C. Scaiano.



University of Barcelona, Barcelona

• Predoctoral Fellow

  • Jan 1996 - Jan 2001



University of Girona

• Student Fellow

  • Jan 1996 - Jun 1996